Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB 100701 Principal Investigator: Vij, Ravi
Title: Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia (CLL)
Phase: II Disease Site: Lymphoid Leukemia
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to find out what effects (good and bad) this treatment has on patients and this type of cancer.

This research is being done to improve the outcomes of patients diagnosed with chronic lymphocytic leukemia who may have high risk features or who have had their disease return after receiving chemotherapy.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)